XPhyto Therapeutic Corporation (XPHYF) Corporate Media Kit

Investment Highlights XPhyto Therapeutics Corporation A next generation bioscience company | World-class drug delivery expertise A pipeline of novel thin-film drug delivery formulations, offering precise, efficient, optimized bioavailability Disruptive diagnostic pipeline Rapid, point-of-care diagnostic and screening tests for infectious diseases and oral health indications Near-term market & exit opportunities A late-stage pipeline of proprietary diagnostics and drug delivery innovations Efficient M&A execution Management committed to building shareholder value through buy & build strategy R&D collaborations Leveraging world-class academic expertise and state-of-the-art facilities in Germany and Canada with limited capital investment Unique Psychedelic Programs First-mover advantage and industry leadership in the development of industrial scale production of pharmaceutical grade psilocybin and mescaline 13